AMPK, an attractive anti-obesity target for exploiting cellular EE, integrates nutritional, hormonal and pharmacological inputs to maintain the cellular energy balance8,9. The gene discussed is PRKAA2; the disease is obesity due to melanocortin 4 receptor deficiency.